HSPD1 and myalgic encephalomeyelitis/chronic fatigue syndrome: In addition, antibodies against endogenous and microbial HSP65 peptides were at the same level in patients with ME/CFS and HCs, with the exception of a higher seroprevalence to an HSP65 peptide derived from Chlamydia pneumoniae in the former [102].